Dermatologic therapy: 1993
Identifieur interne : 002C88 ( Main/Exploration ); précédent : 002C87; suivant : 002C89Dermatologic therapy: 1993
Auteurs : Ralph J. Coskey [États-Unis]Source :
- Journal of the American Academy of Dermatology [ 0190-9622 ] ; 1994.
English descriptors
- Teeft :
- Acad, Acad dermatol, Acne, Acne vulgaris, Acta derm, Acta derm venereol, Acute hepatitis, Alopecia areata, American academy, Antiinflammatory activity, Arch dermatol, Atopic, Atopic dermatitis, Brittle nails, Calcipotriol, Clinical improvement, Clinical trial, Complete remission, Complete remissions, Complete resolution, Coskey, Cutaneous, Cutaneous ulcers, Dermatitis, Dermatol, Dermatology, Dermatology november, Dermatology volume, Doxycycline, Erythromycin, Etretinate, Fungal infection, Furuncular myiasis, Generalized bullous pemphigoid, High doses, Hydroxychloroquine sulfate, Hypertrophic scars, Immune globulin, Interferon, Interferon alfa, Intralesional, Intralesional vinblastine, Itraconazole, Lancet, Lesion, Lichen nitidus, Normal skin, Occlusion, Open study, Open trial, Oral fluconazole, Oral itraconazole, Oral tetracycline, Partial response, Placebo, Potassium iodide, Pruritic psoriasis, Psoriasis, Psoriasis clearance, Psoriasis vulgaris, Remission, Renal, Retinoic, Retinoic acid, Sarcoma, Severe psoriasis, Side effects, Significant improvement, Skin cancer, Solar keratoses, Successful treatment, Tetracycline, Tinea, Tinea cruris, Topical, Topical heparin, Topical tretinoin, Topical tretinoin cream, Tretinoin, Tretinoin cream, Weeksafter treatment, World cutaneous leishmaniasis, Yellow nail syndrome.
Abstract
This article reviews some therapeutic results reported in the English-language literature during 1993. Readers should review the original article in full before attempting any experimental or controversial therapy.
Url:
DOI: 10.1016/S0190-9622(94)70239-X
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001218
- to stream Istex, to step Curation: 001218
- to stream Istex, to step Checkpoint: 001A73
- to stream Main, to step Merge: 002D48
- to stream Main, to step Curation: 002C88
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dermatologic therapy: 1993</title>
<author><name sortKey="Coskey, Ralph J" sort="Coskey, Ralph J" uniqKey="Coskey R" first="Ralph J." last="Coskey">Ralph J. Coskey</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6609463B9E4666C71516D9202935DE586AD2613E</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1016/S0190-9622(94)70239-X</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-Q7BDD90N-H/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001218</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001218</idno>
<idno type="wicri:Area/Istex/Curation">001218</idno>
<idno type="wicri:Area/Istex/Checkpoint">001A73</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001A73</idno>
<idno type="wicri:Area/Main/Merge">002D48</idno>
<idno type="wicri:Area/Main/Curation">002C88</idno>
<idno type="wicri:Area/Main/Exploration">002C88</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dermatologic therapy: 1993</title>
<author><name sortKey="Coskey, Ralph J" sort="Coskey, Ralph J" uniqKey="Coskey R" first="Ralph J." last="Coskey">Ralph J. Coskey</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>From the Dermatology Department, Wayne State University School of Medicine, Detroit, Michigan</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of the American Academy of Dermatology</title>
<title level="j" type="abbrev">YMJD</title>
<idno type="ISSN">0190-9622</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1994">1994</date>
<biblScope unit="volume">31</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="supplement">P1</biblScope>
<biblScope unit="page" from="764">764</biblScope>
<biblScope unit="page" to="774">774</biblScope>
</imprint>
<idno type="ISSN">0190-9622</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0190-9622</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad</term>
<term>Acad dermatol</term>
<term>Acne</term>
<term>Acne vulgaris</term>
<term>Acta derm</term>
<term>Acta derm venereol</term>
<term>Acute hepatitis</term>
<term>Alopecia areata</term>
<term>American academy</term>
<term>Antiinflammatory activity</term>
<term>Arch dermatol</term>
<term>Atopic</term>
<term>Atopic dermatitis</term>
<term>Brittle nails</term>
<term>Calcipotriol</term>
<term>Clinical improvement</term>
<term>Clinical trial</term>
<term>Complete remission</term>
<term>Complete remissions</term>
<term>Complete resolution</term>
<term>Coskey</term>
<term>Cutaneous</term>
<term>Cutaneous ulcers</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatology</term>
<term>Dermatology november</term>
<term>Dermatology volume</term>
<term>Doxycycline</term>
<term>Erythromycin</term>
<term>Etretinate</term>
<term>Fungal infection</term>
<term>Furuncular myiasis</term>
<term>Generalized bullous pemphigoid</term>
<term>High doses</term>
<term>Hydroxychloroquine sulfate</term>
<term>Hypertrophic scars</term>
<term>Immune globulin</term>
<term>Interferon</term>
<term>Interferon alfa</term>
<term>Intralesional</term>
<term>Intralesional vinblastine</term>
<term>Itraconazole</term>
<term>Lancet</term>
<term>Lesion</term>
<term>Lichen nitidus</term>
<term>Normal skin</term>
<term>Occlusion</term>
<term>Open study</term>
<term>Open trial</term>
<term>Oral fluconazole</term>
<term>Oral itraconazole</term>
<term>Oral tetracycline</term>
<term>Partial response</term>
<term>Placebo</term>
<term>Potassium iodide</term>
<term>Pruritic psoriasis</term>
<term>Psoriasis</term>
<term>Psoriasis clearance</term>
<term>Psoriasis vulgaris</term>
<term>Remission</term>
<term>Renal</term>
<term>Retinoic</term>
<term>Retinoic acid</term>
<term>Sarcoma</term>
<term>Severe psoriasis</term>
<term>Side effects</term>
<term>Significant improvement</term>
<term>Skin cancer</term>
<term>Solar keratoses</term>
<term>Successful treatment</term>
<term>Tetracycline</term>
<term>Tinea</term>
<term>Tinea cruris</term>
<term>Topical</term>
<term>Topical heparin</term>
<term>Topical tretinoin</term>
<term>Topical tretinoin cream</term>
<term>Tretinoin</term>
<term>Tretinoin cream</term>
<term>Weeksafter treatment</term>
<term>World cutaneous leishmaniasis</term>
<term>Yellow nail syndrome</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">This article reviews some therapeutic results reported in the English-language literature during 1993. Readers should review the original article in full before attempting any experimental or controversial therapy.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Michigan</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Michigan"><name sortKey="Coskey, Ralph J" sort="Coskey, Ralph J" uniqKey="Coskey R" first="Ralph J." last="Coskey">Ralph J. Coskey</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C88 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C88 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:6609463B9E4666C71516D9202935DE586AD2613E |texte= Dermatologic therapy: 1993 }}
This area was generated with Dilib version V0.6.33. |